Dubai: Medical Experts from Dubai Health Authority’s Innovation Centre have collaborated with Sinterex, an additive manufacturing healthcare specialist firm, to bring 3D Printing to the point-of-care at DHA Hospitals-Rashid, Latifa, Dubai, and Hatta Hospital.
The newly opened 3D Printing Lab located at the DHA’s Innovation Centre provides medical professionals at DHA with patient specific anatomical models allowing them to conduct detailed pre-operative analysis and to improve patient communication.
The workflow starts with patient data acquisition, typically from a CT or MRI scan. This patient data is then brought into medical image segmentation software, which allows the physician to isolate the specific anatomical region of interest. This digital model is then converted into a 3D printable file and produced using the state-of-the -art 3D printers in the lab.
Dr Farida Al Khaja, CEO of Medical Support Services and Chair of Medical Innovation Council at DHA explained that this initiative in is line with the DHA’s vision of incorporating latest medical technology in the health sector with a primary aim to better patient care. Additionally, technology also helps improve efficiencies and reduce costs.
Al Khaja said this initiative in particular will help DHA medical professionals achieve greater surgical success particularly for complex cases.
She added that the lab is an important milestone in the execution of the DHAs 3D Printing Strategy, which focusses on deploying the latest technologies to improve patient outcomes and support the healthcare ecosystem of Dubai to excel in difficult medical surgeries.
Sinterex has deployed its biomedical engineers to operate the 3D lab. Julian Callanan, Managing Director, explained that having the biomedical engineers on site and working side-by-side with the medical professionals, helps boost communication and cooperation and it reduces the time taken to develop the final 3D model.
Mai Al Dossari, Director of the DHA’s Health Innovation Centre, said, ‘This is the first major project in the Innovation Centre since it was inaugurated. The 3D Lab has been involved in supporting DHA’s surgeons in successfully planning and achieving complex surgeries. The Cardiology team at Rashid Hospital used 3D models to pre-operatively plan and test the fitting of Trans Aortic Valve Implants. The Maxillofacial team have produced models of patients’ jaws and skulls taking these into surgery for visual reference and intra-operative monitoring. Whilst at Hatta Hospital, the Orthopedics department has been printing knees and shoulders to support planning for reconstruction surgeries.’
Not only is the initiative good for patients, recent research shows the commercial benefits to bringing 3D printing to the point-of-care.
A recent study published in September by Academic Radiology estimated that hospitals using anatomical models could save more than $3,700 per surgery by reducing time spent in the Operating Theatre. The authors reached their conclusions by analyzing more than 30 different studies related to 3D models used in orthopedic and maxillofacial surgery. Based on that review, they estimated that anatomical models could shorten surgery time by about 62 minutes on average.
Dr Mohammed Al Redha, Director of Project Management Office and Informatics and Smart Health at DHA says, “This is an important strategic step for the DHA. It is also a further example of how the DHA is integrating 3D Printing into its day-to-day workflows to secure better results for its patients.”
According to Gartner, a leading research and advisory company, in 2018, nearly 3% of large hospitals and medical research institutions had 3DP capabilities on site.
Al Redha says, “We are truly proud that we have been able to successfully integrate this technology in workflows. Having a 3D printing lab means that we can produce patient-specific 3D printing models especially needed for complicated surgeries. This initiative is in line with the vision of Dubai’s 3D printing strategy to become a global 3D printing technology hub by 2030.”
For further information, please contact:
Kamakshi Gupta and Noor Nazzal
Communications Analysts- Media Dept.
Dubai Health Authority
About the Dubai Health Authority:
The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement.
Prior to the establishment of the DHA, the Department of Health and Medical Services, which was established in 1973, was the functioning authority that almost exclusively focused on health service delivery.
In May 2018, H.H. Sheikh Mohammed, issued Law No. (6) of 2018 of the DHA. The new Law further enables the DHA to achieve its objectives including regulating medical services in Dubai, enhancing competiveness and transparency, improving medical services and products based on international best practices and achieving the sector’s objectives according to approved strategic plans.
H.H. Sheikh Mohammed also issued Decree No. 17 of 2018 establishing subsidiaries of the DHA: the Dubai Healthcare Corporation and Dubai Health Insurance Corporation to further enhance healthcare services in Dubai and enable DHA to fulfil its responsibilities and obligations.
Three new strategic sectors were also added as part of the decree; they include Strategy and Corporate Development, Health Regulation, and Shared Support Services.
In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including Latifa, Dubai, Rashid and Hatta Hospitals, its 12 primary healthcare centres, 17 medical fitness centres and its 6 specialty centres.
For more information, visit DHA’s website: www.dha.gov.ae© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.